Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials
In 2026, OPM will offer: 47 carriers and 132 plan options in FEHB
Uncertainty about the magnitude and duration of ferroptotic action Developing clinically effective drugs against ferroptosis is a crucial goal of our research
Letters to the editor, commentaries and conference abstracts were also excluded
US$ 25.47
US$ 26.61
US$ 26.99
US$ 28.63
US$ 24.74
US$ 28.42
